SE9803156D0 - A new composition - Google Patents

A new composition

Info

Publication number
SE9803156D0
SE9803156D0 SE9803156A SE9803156A SE9803156D0 SE 9803156 D0 SE9803156 D0 SE 9803156D0 SE 9803156 A SE9803156 A SE 9803156A SE 9803156 A SE9803156 A SE 9803156A SE 9803156 D0 SE9803156 D0 SE 9803156D0
Authority
SE
Sweden
Prior art keywords
composition
component
disorders
new composition
dicyclobutylamino
Prior art date
Application number
SE9803156A
Other languages
English (en)
Inventor
John Evenden
Seth-Olov Thorberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9803156A priority Critical patent/SE9803156D0/sv
Publication of SE9803156D0 publication Critical patent/SE9803156D0/sv
Priority to AU63780/99A priority patent/AU6378099A/en
Priority to SK326-2001A priority patent/SK3262001A3/sk
Priority to HU0103544A priority patent/HUP0103544A3/hu
Priority to PCT/SE1999/001597 priority patent/WO2000015218A1/en
Priority to EEP200100157A priority patent/EE200100157A/xx
Priority to JP2000569802A priority patent/JP2002524508A/ja
Priority to EP99951319A priority patent/EP1128825A1/en
Priority to CA002342341A priority patent/CA2342341A1/en
Priority to IL14151999A priority patent/IL141519A0/xx
Priority to KR1020017003337A priority patent/KR20010099647A/ko
Priority to CN99811010A priority patent/CN1317964A/zh
Priority to TR2001/00779T priority patent/TR200100779T2/xx
Priority to CZ2001961A priority patent/CZ2001961A3/cs
Priority to BR9913748-8A priority patent/BR9913748A/pt
Priority to PL99346763A priority patent/PL346763A1/xx
Priority to IDW20010581A priority patent/ID28785A/id
Priority to ARP990104626A priority patent/AR021808A1/es
Priority to IS5879A priority patent/IS5879A/is
Priority to ZA200101946A priority patent/ZA200101946B/en
Priority to NO20011312A priority patent/NO20011312L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE9803156A 1998-09-16 1998-09-16 A new composition SE9803156D0 (sv)

Priority Applications (21)

Application Number Priority Date Filing Date Title
SE9803156A SE9803156D0 (sv) 1998-09-16 1998-09-16 A new composition
IDW20010581A ID28785A (id) 1998-09-16 1999-09-13 Komposisi
CA002342341A CA2342341A1 (en) 1998-09-16 1999-09-13 A new composition
KR1020017003337A KR20010099647A (ko) 1998-09-16 1999-09-13 신규 조성물
HU0103544A HUP0103544A3 (en) 1998-09-16 1999-09-13 Pharmaceutical composition containing (r)-3-n,n-dicyklobutylamino-8-fluoro-3,4-dihydro-2h-1-benzopyran-5-carboxamide hidrogen-(2r,3r)tartarate monohydrate and paroxetin and process for its preparation
PCT/SE1999/001597 WO2000015218A1 (en) 1998-09-16 1999-09-13 A new composition
EEP200100157A EE200100157A (et) 1998-09-16 1999-09-13 Uus koostis
JP2000569802A JP2002524508A (ja) 1998-09-16 1999-09-13 新規組成物
EP99951319A EP1128825A1 (en) 1998-09-16 1999-09-13 A new composition
AU63780/99A AU6378099A (en) 1998-09-16 1999-09-13 A new composition
IL14151999A IL141519A0 (en) 1998-09-16 1999-09-13 A new composition of (r) -3-n, n-dicyclobutylamino-8-fluoro-3, 4-dihydro-3h-1-benzopyran-5-carboxamide hydrogen (2r, 3r) - tartrate monohydrate and paroxetine
SK326-2001A SK3262001A3 (en) 1998-09-16 1999-09-13 A new composition
CN99811010A CN1317964A (zh) 1998-09-16 1999-09-13 新型组合物
TR2001/00779T TR200100779T2 (tr) 1998-09-16 1999-09-13 Yeni bir bileşim.
CZ2001961A CZ2001961A3 (cs) 1998-09-16 1999-09-13 Nový prostředek
BR9913748-8A BR9913748A (pt) 1998-09-16 1999-09-13 Composição, uso da composição método para o tratamento de distúrbios mediados por 5-ht, método de melhoria do inìcio da ação terapêutica, formulação farmacêutica, processo para a preparação da composição, e, kit
PL99346763A PL346763A1 (en) 1998-09-16 1999-09-13 A new composition
ARP990104626A AR021808A1 (es) 1998-09-16 1999-09-15 Composicion nueva
IS5879A IS5879A (is) 1998-09-16 2001-03-07 Ný efnablanda
ZA200101946A ZA200101946B (en) 1998-09-16 2001-03-08 A new composition.
NO20011312A NO20011312L (no) 1998-09-16 2001-03-15 Ny sammensetning

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803156A SE9803156D0 (sv) 1998-09-16 1998-09-16 A new composition

Publications (1)

Publication Number Publication Date
SE9803156D0 true SE9803156D0 (sv) 1998-09-16

Family

ID=20412627

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9803156A SE9803156D0 (sv) 1998-09-16 1998-09-16 A new composition

Country Status (21)

Country Link
EP (1) EP1128825A1 (sv)
JP (1) JP2002524508A (sv)
KR (1) KR20010099647A (sv)
CN (1) CN1317964A (sv)
AR (1) AR021808A1 (sv)
AU (1) AU6378099A (sv)
BR (1) BR9913748A (sv)
CA (1) CA2342341A1 (sv)
CZ (1) CZ2001961A3 (sv)
EE (1) EE200100157A (sv)
HU (1) HUP0103544A3 (sv)
ID (1) ID28785A (sv)
IL (1) IL141519A0 (sv)
IS (1) IS5879A (sv)
NO (1) NO20011312L (sv)
PL (1) PL346763A1 (sv)
SE (1) SE9803156D0 (sv)
SK (1) SK3262001A3 (sv)
TR (1) TR200100779T2 (sv)
WO (1) WO2000015218A1 (sv)
ZA (1) ZA200101946B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60122015T2 (de) 2000-10-13 2006-11-23 Neurosearch A/S Behandlung affektiver störungen durch kombinierte wirkung eines nikotinischen rezeptoragonisten und einer monoaminergischen substanz
US20090036488A1 (en) * 2005-03-04 2009-02-05 Tokyo Medical And Dental University Recurrence preventive therapeutic agent for psychostimulant-induced psychosis and schizophrenia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination

Also Published As

Publication number Publication date
IL141519A0 (en) 2002-03-10
AR021808A1 (es) 2002-08-07
HUP0103544A3 (en) 2003-12-29
NO20011312D0 (no) 2001-03-15
EP1128825A1 (en) 2001-09-05
WO2000015218A1 (en) 2000-03-23
SK3262001A3 (en) 2001-08-06
CZ2001961A3 (cs) 2001-08-15
JP2002524508A (ja) 2002-08-06
AU6378099A (en) 2000-04-03
HUP0103544A2 (hu) 2002-05-29
KR20010099647A (ko) 2001-11-09
CA2342341A1 (en) 2000-03-23
PL346763A1 (en) 2002-02-25
EE200100157A (et) 2002-08-15
IS5879A (is) 2001-03-07
ZA200101946B (en) 2002-06-10
CN1317964A (zh) 2001-10-17
TR200100779T2 (tr) 2001-10-22
NO20011312L (no) 2001-05-16
ID28785A (id) 2001-07-05
BR9913748A (pt) 2001-07-10

Similar Documents

Publication Publication Date Title
SE9501567D0 (sv) A new combination
BG108207A (en) Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
EE04911B1 (et) Ühend ja farmatseutiline kompositsioon proteaasi inhibiitoritena, nende kasutamine ning meetod selle ühendi valmistamiseks
MXPA04000456A (es) Analogos de prostaglandina como agonistas del receptor ep4.
ECSP055609A (es) "Uso de inhibidores de la IkB-quinasa para el tratamiento del dolor"
SE9800836D0 (sv) New Compounds
IS6520A (is) Ný efnasambönd
RU2004110041A (ru) Фармацевтическая композиция, содержащая габапентин или его аналог и альфа-аминоамид, и ее применение в качестве анальгетика
TW200606164A (en) New compounds
BR0109211A (pt) Compostos com atividade 5-ht1a úteis para o tratamento de distúrbios da retina externa
AR015448A1 (es) COMBINACIoN DE UN INHIBIDOR DE REABSORCIoN DE 5-HT CON UN ANTAGONISTA O AGONISTA PARCIAL DE H5-HT1B, PROCESO PARA SU PREPARACIoN, FORMULACIoN FARMACÉUTICA QUE LA CONTIENE, SU USO PARA PREPARAR MEDICAMENTOS PARA TRATAR TRASTORNOS AFECTIVOS Y KIT QUE CONTIENE DICHA COMBINACIoN
SE0102055D0 (sv) New Compounds
BR0308133A (pt) Forma polimórfica cristalina de cloridrato de irinotecan
EP1254668A3 (en) Combination of a serotonin reuptake inhibitor and a GABA-A alpha 2/3 agonist for use in anxiety and depression
SE0102440D0 (sv) New compound
ATE369348T1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
NO20050903L (no) Nye piperazinyl-pyrazinonderivater for behandling av 5HT-2A reseptorrelaterte forstyrrelser
SE9804126D0 (sv) New pharmaceutical composition
AR035818A1 (es) Fenil-heterociclil-eteres con actividad como inhibidores selectivos de recaptacion de serotonina, composiciones farmaceuticas y su uso en la fabricacion de medicamentos
CR7271A (es) Formulaciones farmaceuticas novedosas a base de melatonina y compuestos similares para su uso en transtornos del sueno
BR0309009A (pt) Método para o tratamento de hipersecreção de muco
SE9702066D0 (sv) A new salt
SE9803157D0 (sv) A new composition
SE9803156D0 (sv) A new composition
SE9803158D0 (sv) A new composition